Search - tctmd.com

Displaying 161 - 180 of 264

Sort: Relevancy | Date

Presentation TCT 2016

Why Is Post-Dilatation Mandatory? Technical And Clinical Considerations (With Case Examples)

Presenter: Jonathan M. Hill, Christoph K. Naber, Azeem Latib

November 01, 2016

Presentation TCT 2016

Direct Flow: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Azeem Latib

November 01, 2016

Presentation TCT 2016

Methods and Technologies to Improve DCB Outcomes: Does the Data Support Their Use?

Presenter: Fernando Alfonso, Juan F. Granada, Azeem Latib

November 01, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

Presentation TCT 2016

Direct Flow TMVR: Design Development Update

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Azeem Latib

October 31, 2016

Presentation TCT 2016

Case #2: A Novel Issue With a Bioresorbable Scaffold

Presenter: Antonio Colombo, Jeffrey W. Moses, Azeem Latib

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty II: Mitralign Trial Results and Future Directions

Presenter: Ted Feldman, Scott Lim, Azeem Latib

October 31, 2016

Presentation TCT 2016

Bail-out Side Branch Stenting After BVS

Presenter: Francesco Burzotta, Dean J. Kereiakes, Azeem Latib

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in Bifurcation Lesions How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Azeem Latib

October 30, 2016

Presentation TCT 2016

Keynote Lecture: Enter the Bioresorbable Scaffold Era: Similarities and Differences From Metallic DES

Presenter: Thomas H. Maloney, Azeem Latib

October 29, 2016

News Daily News

TAVR 可用于治疗二尖瓣主动脉瓣狭窄，但与永久性起搏器植入率更高相关联

Michael O'Riordan

July 05, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Daily News

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Michael O'Riordan

July 05, 2016

Presentation TVT 2016

MitraClip

Presenter: Azeem Latib

June 17, 2016

Presentation TVT 2016

The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR

Presenter: Azeem Latib

June 17, 2016

Presentation TVT 2016

The DIRECT FLOW TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Azeem Latib

June 16, 2016

Presentation TVT 2016

Clinical Implications of New LBBB and New Pacemakers After TAVR

Presenter: Azeem Latib

June 16, 2016

News Daily News

Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways

Michael O'Riordan

May 02, 2016

Presentation CRT 2016

Direct Flow Medical Solutions for Mitral Valve Replacement

Presenter: Azeem Latib

February 20, 2016

Presentation JIM 2016

Mitralign: Transcatheter Repair for Functional Mitral Regurgitation

Presenter: Azeem Latib

February 11, 2016

Advertisement

Why Is Post-Dilatation Mandatory? Technical And Clinical Considerations (With Case Examples)

Direct Flow: Design Features, Special Attributes, and Clinical Trial Program

Methods and Technologies to Improve DCB Outcomes: Does the Data Support Their Use?

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Direct Flow TMVR: Design Development Update

Case #2: A Novel Issue With a Bioresorbable Scaffold

Direct Annuloplasty II: Mitralign Trial Results and Future Directions

Bail-out Side Branch Stenting After BVS

Case Presentations: Bioresorbable Scaffolds in Bifurcation Lesions How to Do It

Keynote Lecture: Enter the Bioresorbable Scaffold Era: Similarities and Differences From Metallic DES

TAVR 可用于治疗二尖瓣主动脉瓣狭窄，但与永久性起搏器植入率更高相关联

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

MitraClip

The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR

The DIRECT FLOW TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Clinical Implications of New LBBB and New Pacemakers After TAVR

Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways

Direct Flow Medical Solutions for Mitral Valve Replacement

Mitralign: Transcatheter Repair for Functional Mitral Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content